Evidence of mitochondrial dysfunction in autism and implications for treatment

American Journal of Biochemistry and Biotechnology

Volumn 4, Issue 2, 2008, Pages 208-217

  Rossignol, Daniel A ^a   Bradstreet, J Jeffrey ^a  

^a International Child Development Resource Center   (United States)

Author keywords

Ammonia; Antioxidants; Co Enzyme Q10; Hyperbaric oxygen therapy; Inflammation; Lactate; Mitochondria; Oxidative stress

Indexed keywords

AMMONIA; DISEASES; METABOLISM; MITOCHONDRIA; OXIDATIVE STRESS; PATHOLOGY;

HYPERBARIC OXYGEN THERAPY; LACTATE; MITOCHONDRIAL DYSFUNCTION (MTD); MITOCHONDRIAL PATHOLOGY;

MEDICAL PROBLEMS;

ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; GINKGO BILOBA EXTRACT; GLUTATHIONE; IDEBENONE; LEVACECARNINE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; UBIDECARENONE;

AUTISM; COGNITIVE DEFECT; COMORBIDITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; FATTY ACID OXIDATION; GASTROINTESTINAL DISEASE; GENETIC DISORDER; HUMAN; HYPERBARIC OXYGEN; LANGUAGE DISABILITY; MITOCHONDRIAL ENCEPHALOMYOPATHY; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEX RATIO; SUPPLEMENTATION;

EID: 42449106018     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2008.208.217     Document Type: Review

References (115)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press.
2. Herbert, M.R, 2005. Autism: a brain disorder, or a disorder that affects the brain? Clin. Neuropsych., 2:354-379.
3. Bertrand, J., A. Mars, C. Boyle, F. Bove, M. Yeargin-Allsopp, P. Decoufle, 2001. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics, 108:1155-1161.
4. Chakrabarti, S., E. Fombonne, 2001. Pervasive developmental disorders in preschool children. JAMA, 285:3093-3099.
5. Baird, G., T. Charman, S. Baron-Cohen, A. Cox, J. Swettenham, S. Wheelwright, A. Drew, 2000. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J. Am. Acad. Child Adolesc. Psychiatry, 39:694-702.
6. Centers for Disease Control and Prevention, 2007. Prevalence of Autism Spectrum Disorders - Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000. M.M.W.R., 56:1-40.
7. Bailey, A., W. Phillips, M. Rutter, 1996. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J. Child. Psychol. Psychiatry, 37:89-126.
8. Zeviani, M., B. Bertagnolio, G. Uziel, 1996. Neurological presentations of mitochondrial diseases. J. Inherit. Metab. Dis., 19:504-520.
9. Filiano, J.J., M.J. Goldenthal, C.H. Rhodes, J. Marin-Garcia, 2002. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J. Child Neurol., 17:435-439.
10. Lerman-Sagie, T., E. Leshinsky-Silver, N. Watemberg, D. Lev, 2004. Should autistic children be evaluated for mitochondrial disorders? J. Child Neurol., 19:379-381.
11. Ramoz, N., J.G. Reichert, C.J. Smith, J.M. Silverman, I.N. Bespalova, K.L. Davis, J.D. Buxbaum, 2004. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry, 161:662-669.
12. Segurado, R., J. Conroy, E. Meally, M. Fitzgerald, M. Gill, L. Gallagher, 2005. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am. J. Psychiatry, 162:2182-2184.
13. Sue, C.M., C. Bruno, A.L. Andreu, A. Cargan, J.R. Mendell, C.Y. Tsao, M. Luquette, J. Paolicchi, S. Shanske, S. DiMauro, D.C. De Vivo, 1999. Infantile encephalopathy associated with the MELAS A3243G mutation. J. Pediatr., 134:696-700.
14. Pons, R., A.L. Andreu, N. Checcarelli, M.R. Vila, K. Engelstad, C.M. Sue, D. Shungu, R. Haggerty, D.C. De Vivo, S. DiMauro, 2004. Mitochondrial DNA abnormalities and autistic spectrum disorders. J. Pediatr., 144:81-85.
15. Serajee, F.J., H. Zhang, A.H.M.M Huq, 2006. Prevalence of common mitochondrial point mutations in autism. Neuropediatrics, 37(Suppl 1):S127.
16. Graf, W.D., J. Marin-Garcia, H.G. Gao, S. Pizzo, R.K. Naviaux, D. Markusic, B.A. Barshop, E. Courchesne, R.H. Haas, 2000. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J. Child Neurol., 15:357-361.
17. Laszlo, A., E. Horvath, E. Eck, M. Fekete, 1994. Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin. Chim. Acta., 229:205-207.
18. Poling, J.S., R.E. Frye, J. Shoffner, A.W. Zimmerman, 2006. Developmental regression and mitochondrial dysfunction in a child with autism. J. Child Neurol., 21:170-172.
19. Nissenkorn, A., A. Zeharia, D. Lev, A. Fatal-Valevski, V. Barash, A. Gutman, S. Harel, T. Lerman-Sagie, 1999. Multiple presentations of mitochondrial disorders. Arch. Dis. Child, 81:209-214.
20. Marin-Garcia, J., R. Ananthakrishnan, M.J. Goldenthal, J.J. Filiano, H.B Sarnat, 1999. Skeletal muscle mitochondrial defects in nonspecific neurologic disorders. Pediatr. Neurol., 21:538-542.
21. Lombard, J., 1998 Autism: a mitochondrial disorder? Med. Hypotheses, 50:497-500.
22. Oliveira, G., L. Diogo, M. Grazina, P. Garcia, A. Ataide, C. Marques, T. Miguel, L. Borges, A.M. Vicente, C.R. Oliveira, 2005. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev. Med. Child Neurol., 47:185-189.
23. Ohta, S., I. Ohsawa, 2006. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. J. Alzheimers Dis., 9:155-166.
24. Manczak, M., T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, P.H. Reddy, 2006. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet., 15:1437-1449.
25. Martin, L.J., 2006. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis. J Neuropathol. Exp. Neurol., 65:1103-1110.
26. Trushina, E., C.T. McMurray, 2007. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience, 145:1233-1248.
27. Billups, B., I.D. Forsythe, 2002. Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci., 22:5840-5847.
28. Minshew, N.J., G. Goldstein, S.M. Dombrowski, K. Panchalingam, J.W. Pettegrew, 1993. A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol. Psychiatry, 33:762-773.
29. Chugani, D.C., B.S. Sundram, M. Behen, M.L. Lee, G.J. Moore, 1999. Evidence of altered energy metabolism in autistic children. Prog. Neuropsychopharmacol. Biol. Psychiatry, 23:635-641.
30. Sherer, T.B., R. Betarbet, A.K. Stout, S. Lund, M. Baptista, A.V. Panov, M.R. Cookson, J.T. Greenamyre, 2002. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci., 22:7006-7015.
31. Hoensch, H., I. Morgenstern, G. Petereit, M. Siepmann, W.H. Peters, H.M Roelofs, W. Kirch, 2002. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut, 50:235-240.
32. Uhlmann, V., C.M. Martin, O. Sheils, L. Pilkington, I. Silva, A. Killalea, S.B. Murch, J. Walker-Smith, M. Thomson, A.J. Wakefield, J.J. O'Leary, 2002. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol. Pathol., 55:84-90.
33. Furlano, R.I., A. Anthony, R. Day, A. Brown, L. McGarvey, M.A. Thomson, S.E. Davies, M. Berelowitz, A. Forbes, A.J. Wakefield, J.A. Walker-Smith, S.H Murch, 2001. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J. Pediatr., 138:366-372.
34. Valicenti-McDermott, M., K. McVicar, I. Rapin, B.K. Wershil, H. Cohen, S. Shinnar, 2006. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J. Dev. Behav. Pediatr., 27(2 Suppl):S128-S136.
35. Chinnery, P.F., D.M. Turnbull, 1997. Mitochondrial medicine. Q.J.M., 90:657-667.
36. Peake, D., L.M. Notghi, S. Philip, 2006. Management of epilepsy in children with autism. Current Paediatrics, 16:489-494.
37. Rapin, I., 1997. Autism. N. Engl. J. Med., 337:97-104.
38. Bell, J.G., E.E. MacKinlay, J.R. Dick, D.J. MacDonald, R.M. Boyle, A.C. Glen, 2004. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fatty Acids, 71:201-204.
39. Infante, J.P., V.A. Huszagh, 2000. Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: a common denominator in the pathophysiology of diseases of oxidative phosphorylation and beta-oxidation. FEBS Lett., 468:1-5.
40. Clark-Taylor, T., B.E. Clark-Taylor, 2004. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses, 62:970-975.
41. Vancassel, S., G. Durand, C. Barthelemy, B. Lejeune, J. Martineau, D. Guilloteau, C. Andres, S. Chalon, 2001. Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids, 65:1-7.
42. Reddy, P.H., 2006. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progress of Alzheimer's disease. J. Neurochem., 96:1-13.
43. Singh, K.K., 2006. Mitochondrial damage checkpoint, aging, and cancer. Ann. N.Y. Acad. Sci. 1067:182-190.
44. Nojiri, H., T. Shimizu, M. Funakoshi, O. Yamaguchi, H. Zhou, S. Kawakami, Y. Ohta, M. Sami, T. Tachibana, H. Ishikawa, H. Kurosawa, R.C. Kahn, K. Otsu, T. Shirasawa, 2006. Oxidative stress causes heart failure with impaired mitochondrial respiration. J. Biol. Chem., 281:33789-33801.
45. James, S.J., P. Cutler, S. Melnyk, S. Jernigan, L. Janak, D.W. Gaylor, J.A. Neubrander, 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr., 80:1611-1617.
46. James, S.J., S. Melnyk, S. Jernigan, M.A. Cleves, C.H. Halsted, D.H. Wong, P. Cutler, K. Bock, M. Boris, J.J. Bradstreet, S.M. Baker, D.W. Gaylor, 2006. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 141:947-956.
47. Yorbik, O., A. Sayal, C. Akay, D.I. Akbiyik, T. Sohmen, 2002. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot. Essent. Fatty Acids, 67:341-343.
48. Cadenas, E., K.J. Davies, 2000. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med., 29:222-230.
49. Albers, D.S., M.F. Beal, 2000. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural. Transm. Suppl., 59:133-154.
50. Chauhan, A., V. Chauhan, 2006. Oxidative stress in autism. Pathophysiology, 13:171-181.
51. Dickinson, D.A., H.J. Forman, 2002. Glutathione in defense and signaling: lessons from a small thiol. Ann. N. Y. Acad. Sci., 973:488-504.
52. Zoroglu, S.S., F. Armutcu, S. Ozen, A. Gurel, E. Sivasli, O. Yetkin, I. Meram, 2004. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur. Arch. Psychiatry Clin. Neurosci., 254:143-147
53. D'Amelio, M., I. Rica, R. Sacco, X. Liu, L. D'Agruma, L.A. Muscarella, V. Guarnieri, R. Militerni,. C. Bravaccio, M. Elia, C. Schneider, R. Melmed, S. Trillo, T. Pascucci, S. Puglisi-Allegra, K.L. Reichelt, F. Macciardi, J.J. Holden, A.M Persico, 2005. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol. Psychiatry, 10:1006-1016.
54. Yao, Y., W.J. Walsh, W.R. McGinnis, D. Pratico, 2006. Altered vascular phenotype in autism: correlation with oxidative stress. Arch. Neurol., 63:1161-1164.
55. Chauhan, A., V. Chauhan, W.T. Brown, I. Cohen, 2004. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci., 75:2539-2549.
56. Borras, C., J. Sastre, D. Garcia-Sala, A. Lloret, F.V. Pallardo, J. Vina, 2003. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med., 34:546-552.
57. Kume-Kick, J., D.C. Ferris, I. Russo-Menna, M.E. Rice, 1996. Enhanced oxidative stress in female rat brain after gonadectomy. Brain Res., 738:8-14.
58. Carrillo, M.C., S. Kanai, Y. Sato, K. Kitani, 1992. Age-related changes in antioxidant enzyme activities are region and organ, as well as sex, selective in the rat. Mech. Ageing Dev., 65:187-198.
59. Ha, E.Jj, A.M. Smith, 2003. Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. J. Am. Coll. Nutr., 22:43-51.
60. Stirone, C., S.P. Duckles, D.N. Krause, V. Procaccio, 2005. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol. Pharmacol., 68:959-965.
61. Coleman, M., J.P. Blass, 1985. Autism and lactic acidosis. J. Autism Dev. Disord., 15:1-8.
62. Moreno, H., L. Borjas, A. Arrieta, L. Saez, A. Prassad, J. Estevez, E. Bonilla, 1992. [Clinical heterogeneity of the autistic syndrome: a study of 60 families]. Invest. Clin., 33:13-31.
63. Filipek, P.A., J. Juranek, M. Smith, L.Z. Mays, E.R. Ramos, M. Bocian, D. Masser-Frye, T.M. Laulhere, C. Modahl, M.A. Spence, J.J Gargus, 2003. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann. Neurol., 53:801-804.
64. Filipek, P.A., J. Juranke, M.T. Nguyen, C. Cummings, J.J. Gargus, 2004. Relative carnitine deficiency in autism. J. Autism Dev. Disord., 34:615-23.
65. Correia, C., A.M. Coutinho, L. Diogo, M. Grazina, C. Marques, T. Miguel, A. Ataide, J. Almeida, L. Borges, C. Oliveira, G. Oliveira, A.M. Vicente, 2006. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J. Autism Dev. Disord.,36:1137-1140.
66. Görker, I., U. Tüzün, 2005. Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl. J. Psychiatry Neurosci., 30:133-135.
67. Kosenko, E., Y. Kaminsky, E. Grau, M.D. Minana, G. Marcaida, S. Grisolia, V. Felipo, 1994. Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+,K(+)-ATPase. J. Neurochem., 63:2172-2178.
68. Rodier, P.M., S.L. Hyman, 1998. Early environmental factors in autism. Mental Retard. Dev. Disabil. Res. Rev., 4:121-128.
69. Stromland, K., V. Nordin, M. Miller, B. Akerstrom, C. Gillberg, 1994. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol., 36:351-356.
70. Chess, S., P. Fernandez S. Korn, 1978. Behavioral consequences of congenital rubella. J. Pediatr., 93:699-703.
71. Yamashita, Y., C. Fujimoto, E. Nakajima, T. Isagai, T. Matsuishi, 2003. Possible association between congenital cytomegalovirus infection and autistic disorder. J. Autism Dev. Disord., 33:455-459.
72. Worth, J., 2002. Paraoxonase polymorphisms and organophosphates. Lancet, 360:802-803.
73. Edelson, S.B., D.S. Cantor, 1998. Autism: xenobiotic influences. Toxicol. Ind. Health, 14:799-811.
74. Windham, G.C., L. Zhang, R. Gunier, L.A. Croen, J.K. Grether, 2006. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environ. Health Perspect., 114:1438-1444.
75. Edelson, S.B., D. Cantor, 2000. The neurotoxic etiology of the autistic spectrum disorders: a replication study. Toxicol. Indust. Health, 16:239-247.
76. Grandjean, P., P.J. Landrigan, 2006. Developmental neurotoxicity of industrial chemicals. Lancet, 368:2167-2178.
77. Bernard, S., A. Enayati, L. Redwood, H. Roger, T. Binstock, 2001. Autism: a novel from of mercury poisoning. Med. Hypotheses, 56:462-471.
78. Palmer, R.F., S. Blanchard, Z. Stein, D. Mandell, C. Miller, 2006. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place, 12:203-209.
79. Eppright, T.D., J.A. Sanfacon, E.A. Horwitz, 1996. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. Missouri Medicine, 93:136-138.
80. Lidsky, T.I., J.S. Schneider, 2005. Autism and autistic symptoms associated with childhood lead poisoning. J. Appl. Research, 5:80-87.
81. Swartzwelder, H.S., W. Holahan, R.D. Myers, 1983. Antagonism by d-amphetamine of trimethyltin-induced hyperactivity evidence toward an animal model of hyperkinetic behavior. Neuropharmacology, 22:1049-1054.
82. Yee, S., B.H. Choi, 1996. Oxidative Stress in neurotoxic effects of methylmercury poisoning. NeuroToxicology, 17:17-26.
83. Shenker, B.J., T.L. Guo, I. O, I.M. Shapiro, 1999. Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol. Appl. Pharmacol., 157:23-35.
84. Pulido, M.D., A.R. Parrish, 2003. Metal-induced apoptosis: mechanisms. Mut. Res., 533:227-241.
85. Yamano, T., S. Morita, 1995. Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes II. Arch. Environ. Contam. Toxicol., 28:1-7.
86. Hiura, T.S., N. Li, R. Kaplan, M. Horwitz, J.C. Seagrave, A.E. Nel, 2000. The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particles. J. Immunol., 165:2703-2711.
87. MacFabe, D.F., D.P. Cain, K. Rodriguez-Capote, A.E. Franklin, J.E. Hoffman, F. Boon, A.R. Taylor, M. Kavaliers, K.P. Ossenkopp, 2007. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res., 176:149-169.
88. Kern, J.K., A.M. Jones, 2006. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J. Toxicol. Environ. Health. B Crit. Rev., 9:485-499.
89. Hagen, T.M., R.T. Ingersoll, C.M. Wehr, J. Lykkesfeldt, V. Vinarsky, J.C. Bartholomew, M.H. Song, B.N Ames, 1998. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Natl. Acad. Sci. U.S.A., 95:9562-9566.
90. Matthews, R.T., L. Yang, S. Browne, M. Baik, M.F. Beal, 1998. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. U.S.A., 95:8892-8897.
91. Sobreira, C., M. Hirano, S. Shanske, R.K. Keller, R.G. Haller, E. Davidson, F.M. Santorelli, A.F. Miranda, E. Bonilla, D.S. Mojon, A.A. Barreira, M.P. King, S. DiMauro, 1997. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology, 48:1238-1243.
92. Ihara, Y., R. Namba, S. Kuroda, T. Sato, T. Shirabe, 1989. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone. J. Neurol. Sci., 90:263-271.
93. Chen, R.S., C.C. Huang, N.S. Chu, 1997. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur. Neurol., 37:212-218.
94. Sastre, J., A. Lloret, C. Borras, J. Pereda, D. Garcia-Sala, M.T. Droy-Lefaix, F.V. Pallardo, J. Vina, 2002. Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver. Cell Mol. Biol. (Noisy-le-grand), 48:685-692.
95. Perez-Pinzon, M.A., P.L. Mumford, M. Rosenthal, T.J. Sick, 1997. Antioxidants, mitochondrial hyperoxidation and electrical recovery after anoxia in hippocampal slices. Brain Res., 754:163-170.
96. Dolske, M.C., J. Spollen, S. McKay, E. Lancashire, L. Tolbert, 1993. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog. Neuropsychopharmacol. Biol. Psychiatry, 17:765-774.
97. Zilbovicius, M., N. Boddaert, P. Belin, J.B. Poline, P. Remy, J.F. Mangin, L. Thivard, C. Barthelemy, Y. Samson, 2000. Temporal lobe dysfunction in childhood autism: a PET study. Am. J. Psychiatry, 157:1988-1993.
98. Ohnishi, T., H. Matsuda, T. Hashimoto, T. Kunihiro, M. Nishikawa, T. Uema, M. Sasaki, 2000. Abnormal regional cerebral blood flow in childhood autism. Brain, 123:1838-1844.
99. Boddaert, N., M. Zilbovicius, 2002. Functional neuroimaging and childhood autism. Pediatr. Radiol., 32:1-7.
100. Rossignol, D.A, 2007. Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Med. Hypotheses, 68:1208-1227.
101. Fatemi, S.H., A.R. Halt, 2001. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse, 42:281-284.
102. Araghi-Niknam, M., S.H Fatemi, 2003. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol. Neurobiol., 23:945-952.
103. Graeber, T.G., J.F. Peterson, M. Tsai, K. Monica, A,J, Fornace Jr, A.J Giaccia, 1994. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell Biol., 14:6264-6277.
104. Shimizu, S., Y. Eguchi, W. Kamiike, Y. Itoh, J. Hasegawa, K. Yamabe, Y. Otsuki, H. Matsuda, Y. Tsujimoto, 1996. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res., 56:2161-2166.
105. Magalhães, J., A. Ascensão, J.M. Soares, R. Ferreira, M.J. Neuparth, F. Marques, J.A. Duarte, 2005. Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. J. Appl. Physiol., 99:1247-1253.
106. Calvert, J.W., J.H. Zhang, 2007. Oxygen treatment restores energy status following experimental neonatal hypoxia-ischemia. Pediatr. Crit. Care Med., 8:165-173.
107. Lane, N., 2002. Oxygen: the molecule that made the world. Oxford University Press, p. 166-167.
108. Dave, K.R., R. Prado, R. Busto, A.P. Raval, W.G. Bradley, D. Torbati, M.A. Perez-Pinzon, 2003. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience, 120:113-120.
109. Daugherty, W.P., J.E. Levasseur, D. Sun, G.L. Rockswold, M.R. Bullock, 2004. Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. J. Neurosurg., 101:499-504.
110. Boveris, A., B. Chance, 1973. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem. J., 134:707-716.
111. Gosalvez, M., J. Castillo Olivares, E. De Miguel, M. Blanco, D. Figuera, 1973. Mitochondrial respiration and oxidative phosphorylation during hypothermic hyperbaric hepatic preservation. J. Surg. Res., 15:313-318.
112. Bar-Sagie, D., A. Mayevsky, B. Bartoov, 1981. Effects of hyperbaric oxygenation on spermatozoan motility driven by mitochondrial respiration. J. Appl. Physiol., 50:531-537.
113. Lou, M., Y. Chen, M. Ding, C.C. Eschenfelder, G. Deuschl, 2006. Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res. Bull., 69:109-116.
114. Gutsaeva, D.R., H.B. Suliman, M.S. Carraway, I.T. Demchenko, C.A. Piantadosi, 2006. Oxygen induced mitochondrial biogenesis in the rat hippocampus. Neuroscience, 137:493-504.
115. Rossignol, D.A., L.W. Rossignol, 2006. Hyperbaric oxygen therapy may improve symptoms in autistic children. Med. Hypotheses, 67:216-228.